AUA: Atenolol linked to drop in low-, intermediate-risk prostate cancer
(HealthDay)—Atenolol is associated with a reduction in incident intermediate- and low-risk prostate cancer (PCa), according to a study presented at the annual meeting of the American Urological Association, held from May ...
May 6, 2019
0
1